General session I and opening ceremony

 General hepatology
 Webcasted session

Main Plenary
English
Science/Research
12 April 2018 13:30 - 15:30


Presentations

Opening Ceremony
12 April 2018 13:30 - 14:00

GS-001 Epidemiology, predictors and outcomes of multi drug resistant bacterial infections in patients with cirrhosis across the world. Final results of the "Global study"
Salvatore Piano , Italy
12 April 2018 14:00 - 14:15

Abstract
GS-002 Cenicriviroc treatment for adults with non-alcoholic steatohepatitis: Year 2 analysis of the Phase 2b CENTAUR study
Vlad Ratziu , France
12 April 2018 14:15 - 14:30

Abstract
GS-003 Sorafenib with versus without concurrent conventional transarterial chemoembolization (cTACE) in patients with advanced hepatocellular carcinoma (HCC): Results from a multicenter, open-label, randomized, controlled phase III STAH trial
Joong-Won Park , Korea, Rep. of South
12 April 2018 14:30 - 14:45

Abstract
GS-004 Integrative molecular classification of extrahepatic cholangiocarcinoma
Robert Montal , Spain
12 April 2018 14:45 - 15:00

Abstract
GS-005 Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection
Heiner Wedemeyer , Germany
12 April 2018 15:00 - 15:15

Abstract
GS-006 Efficacy and safety of 8 weeks of elbasvir/grazoprevir in HCV GT4-infected treatment-naïve participants
Tarik Asselah , France
12 April 2018 15:15 - 15:30

Abstract